Christi Shaw - Executive Chairperson, Director at Kyverna Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairperson, Director
Issuer Symbol
KYTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christi Shaw since 10 Feb 2025

Holdings reported by Christi Shaw for Kyverna Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 70,935 $561,095 $7.91 12 Jan 2026 Direct
Stock Option (right to buy) 185,000 12 Jan 2026 Direct Common Stock

Transactions reported by Christi Shaw for Kyverna Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.